Five days after giving birth, Melissa Crespo was already back on the streets, recovering in a damp, litter-strewn water tunnel, when she got the call from the hospital.
Exploring PRM-A as a novel glycan-targeted therapy for SARS-CoV-2 inhibition
HIV, Ebola and most recently, COVID-19 viruses have had an enormous impact on our societies world-wide.